Nanoparticles–SIRT1 Prevents Endothelial Progenitor Cells Senescence by Modulating Nitric Oxide Expression and Reducing Poly ADP-ribose Polymerase: In vitro Study
DOI:
https://doi.org/10.48048/tis.2024.7519Keywords:
Endothelial progenitor cells, Nitric oxide, Poly-(ADP-Ribose)-polymerase, Sirtuin-1, Cardiovascular diseaseAbstract
One of cardiovascular diseases that accounts for a high global death rate is atherosclerosis. Apart from the known risk factors, the cause of this disease is uncertain. This disease is triggered by the rupture of atheroma. This condition is associated with oxidative stress, which can trigger endothelial progenitor cells (EPC) dysfunction. One of the causes of oxidative stress is hydrogen peroxide, which triggers deoxyribose nucleotide acid (DNA) damage, which will later trigger ageing in EPC. Sirtuin-1 (SIRT1) is known to be involved in EPC repair, but currently, no studies have attempted to increase SIRT1 expression in vitro. This study aimed to determine the effect of nanoparticles-SIRT1 (NPS1) on the expression of nitric-oxide (NO) and poly (ADP-ribose)-polymerase (PARP) in EPC cell cultures induced by hydrogen peroxide (H2O2). Tests were carried out in vitro using EPC cell cultures to determine the potential of SIRT1 (NPS1) nanoparticles as an ageing inhibitor. The research method used was pure quantitative experimental with a post-test-only control group. The expression of NO and PARP was studied using the flow cytometry method. The data obtained were analysed using parametric one-way ANOVA and post-hoc Tukey-HSD tests with a 95 % confidence interval (p ≤ 0.05). The results showed that administration of SIRT1 nanoparticles was able to increase NO expression in EPC culture cells that induced H2O2 by 14.61 % and could also increase NO levels in normal EPC cells that were only given NPS1 by 38.51 % and was able to reduce PARP expression when compared with the normal group. The NPS1 given was 9.03 % for the NPS1 group and 19.78 % for the NPS1+ H2O2 group. This study concludes that NPS1 added to EPC cells further helps increase cell repair to prevent senescence, through increasing NO and also increasing the performance of PARP.
HIGHLIGHTS
- This study aims to determine the effect of Sirtuin-1 (SIRT1) nanoparticles on nitric oxide (NO) and poly (ADP-ribose)-polymerase (PARP) expression in their role as senescence blockers in endothelial progenitor cells (EPC) by maintaining SIRT1 levels to keep EPC cells alive and functioning optimally
- This research succeeded in modulating NO levels with a significant increase in NO.
- This study found that Nanoparticles–SIRT1 (NPS1) added to EPC cells further helps increase cell repair to prevent senescence, through increasing NO and also increasing the performance of PARP as an enzyme that functions in the DNA repair response at levels that are not excessive and does not exceed SIRT1 levels in cells.
GRAPHICAL ABSTRACT
Downloads
Metrics
References
World Health Organization. Cardiovascular diseases (CVDs), Available at: http://www.who.int/mediacentre/factsheets/fs317/en/, accessed August 2023.
M Rafieian-Kopaei, M Setorki, M Doudi, A Baradaran and H Nasri. Atherosclerosis: Process, indicators, risk factors and new hopes. Int. J. Prev. Med. 2014; 5, 927-46.
K Kumboyono, IN Chomsy, FN Aini and TA Wihastuti. Correlation pattern of oxLDL, cortisol, hsCRP, and adiponectin levels in atherosclerosis risk population-based on framingham risk score. Pharmacog. J. 2022; 14, 14-20.
Y Higashi. Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease. Antioxidants 2022; 11, 1958.
P Marchio, S Guerra-Ojeda, JM Vila, M Aldasoro, VM Victor and MD Mauricio. Targeting early atherosclerosis: A focus on oxidative stress and inflammation. Oxid. Med. Cell. Longev. 2019; 2019, 8563845.
S Zha, Z Li, Q Cao, F Wang and F Liu. PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity. Stem Cell Res. Ther. 2018; 9, 224
MG Scioli, G Storti, F D'Amico, R Rodríguez Guzmán, F Centofanti, E Doldo, EMC Miranda and A Orlandi. Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: Potential diagnostic biomarkers and therapeutic targets. J. Clin. Med. 2020; 9, 1995.
A Pańczyszyn, E Boniewska-Bernacka and A Goc. The role of telomeres and telomerase in the senescence of postmitotic cells. DNA Repair 2020; 95, 102956.
R Bretón-Romero and S Lamas. Hydrogen peroxide signaling in vascular endothelial cells. Redox Biol. 2014; 2, 529-34.
H Sies. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 2017; 11, 613-9.
Y Higashi, Y Kihara and K Noma. Endothelial dysfunction and hypertension in aging. Hypertens. Res. 2012; 35, 1039-47.
M Vasa, K Breitschopf, AM Zeiher and S Dimmeler. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res. 2000; 87, 540-2.
A Tapodi, Z Bognar, C Szabo, F Gallyas, B Sumegi and E Hocsak. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phosphor-ATM-NEMO-Akt-mTOR signalosome. Biochem. Pharmacol. 2019; 162, 98-108.
C Szabo. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br. J. Pharmacol. 2009; 156, 713-27.
Y Yang, Y Liu, Y Wang, Y Chao, J Zhang,Y Jia, J Tie and D Hu. Regulation of SIRT1 and its roles in inflammation. Front. Immunol. 2022; 13, 831168.
HT Chung and Y Joe. Antagonistic crosstalk between SIRT1, PARP-1, and -2 in the regulation of chronic inflammation associated with aging and metabolic diseases. Integr. Med. Res. 2014; 3, 198-203.
J Jeong, K Juhn, H Lee, SH Kim, BH Min, KM Lee, MH Cho, GH Park and KH Lee. SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp. Mol. Med. 2007; 39, 8-13.
TF Liu and CE McCall. Deacetylation by SIRT1 reprograms inflammation and cancer. Genes Cancer 2013; 4, 135-47.
DK Alves-Fernandes, MG Jasiulionis. The role of SIRT1 on DNA damage response and epigenetic alterations in cancer. Int. J. Mol. Sci. 2019; 20, 3153.
Z Mei, X Zhang, J Yi, J Huang, J He and Y Tao. Sirtuins in metabolism, DNA repair and cancer. J. Exp. Clin. Cancer Res. 2016; 35, 182.
M Kitada, Y Ogura and D Koya. The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis. Aging 2016; 8, 2290-307.
B Tian and J Liu. Resveratrol: A review of plant sources, synthesis, stability, modification and food application. J. Sci. Food Agr. 2020; 100, 1392-404.
A Pudlarz and J Szemraj. Nanoparticles as carriers of proteins, peptides and other therapeutic molecules. Open Life Sci. 2018; 13, 285-98.
AZ Wilczewska, K Niemirowicz, KH Markiewicz and H Car. Nanoparticles as drug delivery systems. Pharmacol. Rep. 2012; 64, 1020-37.
AO Robb, NL Mills, IB Smith, A Short, O Tura-Ceide, GR Barclay, A Blomberg, HO Critchley, DE Newby and FC Denison. Influence of menstrual cycle on circulating endothelial progenitor cells. Hum. Reprod. 2009; 24, 619-25.
AG Luque-Alcaraz, J Lizardi-Mendoza, FM Goycoolea, I Higuera-Ciapara and W Argüelles-Monal. Preparation of chitosan nanoparticles by nanoprecipitation and their ability as a drug nanocarrier. RSC Adv. 2016; 6, 59250-6.
X Chen, Y Lu, Z Zhang, J Wang, H Yang and G Liu. Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology. Immunology 2015; 145, 455-67.
D Tousoulis, AM Kampoli, C Tentolouris, N Papageorgiou and C Stefanadis. The role of nitric oxide on endothelial function. Curr. Vasc. Pharmacol. 2012; 10, 4-18.
K Kumboyono, IN Chomsy, DH Firdaus, EP Cintya and TA Wihastuti. The biophysical perspective of the vascular alteration due to angiogenesis and inflammation in population at risk of atherosclerosis. AIP Conf. Proc. 2022; 2513, 020013.
LV Souza, FD Meneck, V Oliveira, EM Higa, EH Akamine and MC Franco. Detrimental impact of low birth weight on circulating number and functional capacity of endothelial progenitor cells in healthy children: Role of angiogenic factors. J. Pediatr. 2019; 206, 72-77.e1
T Meng, W Qin and B Liu. Sirt1 antagonizes oxidative stress in diabetic vascular complication. Front. Endocrinol. 2020; 11, 568861.
AWC Man, Y Zhou, N Xia and H Li. Endothelial nitric oxide synthase in the perivascular adipose tissue. Biomedicines 2022; 10, 1754.
A Gamboa, C Shibao, A Diedrich, SY Paranjape, G Farley, B Christman, SR Raj, D Robertson and I Biaggioni. Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension 2008; 51, 1531-6.
M Hermann, A Flammer and TF Lüscher. Nitric oxide in hypertension. J. Clin. Hypertens. 2006; 8, 17-29.
DK Alves-Fernandes and MG Jasiulionis. The role of SIRT1 on DNA damage response and epigenetic alterations in cancer. Int. J. Mol. Sci. 2019; 20, 3153.
MA Demény and L Virág. The PARP enzyme family and the hallmarks of cancer part 1. cell intrinsic hallmarks. Cancers 2021; 13, 2042.
Y Wang, W Luo and Y Wang. PARP-1 and its associated nucleases in DNA damage response. DNA Repair 2019; 81, 10265.
Y Wang, VL Dawson and TM Dawson. Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos. Exp. Neurol. 2009; 218, 193-202.
S Tagawa, C Nakanishi, M Mori, T Yoshimuta, S Yoshida, M Shimojima, J Yokawa, M Kawashiri, M Yamagishi and K Hayashi. Determination of early and late endothelial progenitor cells in peripheral circulation and their clinical association with coronary artery disease. Int. J. Vasc. Med. 2015; 2015, 674213.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
